MX343326B - Metodos para mejorar el metabolismo energetico. - Google Patents

Metodos para mejorar el metabolismo energetico.

Info

Publication number
MX343326B
MX343326B MX2011001733A MX2011001733A MX343326B MX 343326 B MX343326 B MX 343326B MX 2011001733 A MX2011001733 A MX 2011001733A MX 2011001733 A MX2011001733 A MX 2011001733A MX 343326 B MX343326 B MX 343326B
Authority
MX
Mexico
Prior art keywords
energy metabolism
methods
animals
enhancing energy
decline
Prior art date
Application number
MX2011001733A
Other languages
English (en)
Other versions
MX2011001733A (es
Inventor
Pan Yuanlong
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2011001733A publication Critical patent/MX2011001733A/es
Publication of MX343326B publication Critical patent/MX343326B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/121—Heterocyclic compounds containing oxygen or sulfur as hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Abstract

La presente invención se refiere a isoflavonas de soya para usarse en la elaboración de una composición para incrementar el metabolismo energético en un canino en necesidad del mismo, indicado como un canino sano para quien lo necesita o para quien se dese el incremento del metabolismo energético, en donde la composición está adaptada para ser administrable al canino por vía oral. Las isoflavonas son administrables al canino en cantidades de 0.001 a 10 g/kg/día.
MX2011001733A 2008-08-15 2009-08-10 Metodos para mejorar el metabolismo energetico. MX343326B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18903608P 2008-08-15 2008-08-15
PCT/US2009/004584 WO2010019212A2 (en) 2008-08-15 2009-08-10 Methods for enhancing energy metabolism

Publications (2)

Publication Number Publication Date
MX2011001733A MX2011001733A (es) 2011-04-11
MX343326B true MX343326B (es) 2016-11-01

Family

ID=41669526

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011001733A MX343326B (es) 2008-08-15 2009-08-10 Metodos para mejorar el metabolismo energetico.

Country Status (11)

Country Link
US (1) US8835490B2 (es)
EP (1) EP2320889A4 (es)
JP (1) JP2012504554A (es)
CN (1) CN102300569A (es)
AU (1) AU2009282482B2 (es)
BR (1) BRPI0917866A2 (es)
CA (1) CA2733907C (es)
MX (1) MX343326B (es)
RU (1) RU2513133C2 (es)
WO (1) WO2010019212A2 (es)
ZA (1) ZA201101934B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070092577A1 (en) * 2005-10-03 2007-04-26 University Of Tennessee Research Foundation Dietary calcium for reducing the production of reactive oxygen species
MX348902B (es) * 2011-04-20 2017-07-03 Nestec Sa Métodos y composiciones adecuados para prevenir y tratar hiperleptinemia.
EP3466418A1 (en) 2011-07-15 2019-04-10 NuSirt Sciences, Inc. Compositions and methods for modulating metabolic pathways
US9198454B2 (en) 2012-03-08 2015-12-01 Nusirt Sciences, Inc. Compositions, methods, and kits for regulating energy metabolism
MX356263B (es) * 2012-08-23 2018-05-21 Nestec Sa Metodos para el manejo de la perdida de peso y la masa corporal.
WO2014078459A1 (en) 2012-11-13 2014-05-22 Nusirt Sciences, Inc. Compositions and methods for increasing energy metabolism
WO2014152016A1 (en) 2013-03-15 2014-09-25 Nusirt Sciences, Inc. Leucine and nicotinic acid reduces lipid levels
WO2014175119A1 (ja) 2013-04-26 2014-10-30 松谷化学工業株式会社 エネルギー消費の促進および／またはエネルギー消費機能低下の治療および／または予防剤、または方法
RU2651277C2 (ru) * 2013-06-28 2018-04-19 Нестек С.А. Композиции и способы для повышения физической работоспособности
EP3110507B1 (en) 2014-02-27 2020-11-18 NuSirt Sciences, Inc. Compositions and methods for the reduction or prevention of hepatic steatosis
BR112020002872A2 (pt) * 2017-09-12 2020-08-04 Société des Produits Nestlé S.A. métodos para simular a restrição calórica crônica e para conferir benefícios de saúde a um animal

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5952374A (en) * 1997-09-29 1999-09-14 Protein Technologies International, Inc. Method for inhibiting the development of Alzheimer's disease and related dementias- and for preserving cognitive function
ATE549939T1 (de) * 1999-02-24 2012-04-15 Iams Company Diätzusammensetzungen und verfahren
AU6053900A (en) * 1999-06-25 2001-01-31 Morris Notelovitz Compositions for treating or preventing neurodegeneration and cognitive decline
JP2002020304A (ja) * 2000-07-07 2002-01-23 Fancl Corp 食品組成物
EP1300404A1 (en) * 2000-07-07 2003-04-09 Nichimo Co., Ltd Obesity inhibitory materials
KR20030088453A (ko) * 2001-03-09 2003-11-19 소시에떼 데 프로듀이 네슬레 소시에떼아노님 연령 관련 생리학적 부전 개선 및 수명 연장을 위한 조성물
WO2004039327A2 (en) * 2002-10-29 2004-05-13 Colorado State University Research Foundation Use of equol for treating androgen mediated diseases
KR100520408B1 (ko) * 2003-03-25 2005-10-10 주식회사 태평양 비만개선용 조성물
CA2559974C (en) * 2004-03-17 2012-08-14 Nestec S.A. Compositions and methods for reducing or preventing obesity
WO2005107780A2 (en) * 2004-05-10 2005-11-17 Instituto Tecnológico Y De Estudios Superiores De Monterrey (Itesm) Cancer cell growth inhibition by black bean (phaseolus vulgarisl) extracts
SE529185C2 (sv) * 2005-10-07 2007-05-22 Arla Foods Amba Användning av probiotiska bakterier för tillverkning av livsmedel eller läkemedel för förhindrande av övervikt
EP1956923A1 (en) * 2005-11-02 2008-08-20 Nestec S.A. Isoflavone compositions for reducing accumulation of body fat in male mammals, and methods for their use
JP5227195B2 (ja) * 2006-02-28 2013-07-03 ネステク ソシエテ アノニム 骨成長の誘発及び骨損失の抑制のための組成物及び方法

Also Published As

Publication number Publication date
CA2733907A1 (en) 2010-02-18
WO2010019212A2 (en) 2010-02-18
EP2320889A4 (en) 2016-09-21
BRPI0917866A2 (pt) 2016-11-29
MX2011001733A (es) 2011-04-11
AU2009282482B2 (en) 2015-11-26
ZA201101934B (en) 2013-03-27
CN102300569A (zh) 2011-12-28
RU2513133C2 (ru) 2014-04-20
WO2010019212A3 (en) 2016-03-24
AU2009282482A1 (en) 2010-02-18
US8835490B2 (en) 2014-09-16
EP2320889A2 (en) 2011-05-18
JP2012504554A (ja) 2012-02-23
CA2733907C (en) 2019-03-12
US20110165125A1 (en) 2011-07-07
RU2011109455A (ru) 2012-09-20

Similar Documents

Publication Publication Date Title
MX343326B (es) Metodos para mejorar el metabolismo energetico.
MY151018A (en) Use of nutritional compositions for preventing disorders
MY176679A (en) Use of nutritional compositions for preventing disorders
GB201318761D0 (en) Compounds for the treatment of neuropsychiatric disorders
MY156243A (en) Treatment for diabetes in patients inappropriate for metformin therapy
IN2012DN02624A (es)
MX2010005909A (es) Combinacion de inhibidores de fosfatasa de proteina tirosina y hormona de crecimiento humana para el tratamiento de atrofia muscular y trastornos relacionados.
MX2010004074A (es) Combinacion 059.
MX2009006466A (es) Metodos de tratamiento de cancer con inhibidores del receptor del factor 1 de crecimiento similar a la insulina.
TW200942552A (en) Combination therapy with c-Met and HER antagonists
IN2012DN00624A (es)
MY153948A (en) Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof
UA90048C2 (ru) Кондиционированная композиция и способ ее получения
GB2463833A (en) Methods and compositions for the treatment of neurological disorders
IN2012DN02018A (es)
MY150602A (en) Subtituted-quinoxaline-type piperidine compounds and the uses thereof
MX2012013787A (es) Composiciones y metodos para estimular magp-1 y mejorar la apariencia de la piel.
GT200600115A (es) Metodo para identificar blancos terapeuticos para el tratamiento de atrofia vulvoginal
MX2013007189A (es) Metodos y composiciones adecuados para manejar glucosa en sangre en animales.
MX2009006672A (es) Efectos combinados de topiramato y ondansetron sobre el consumo de alcohol.
EP2633052A4 (en) TREATMENT OF DISEASES ASSOCIATED WITH THE INTERFERON 1-RELATED DEVELOPMENT REGULATOR (IFRD1) BY INHIBITING THE NATURAL ANTISENSE TRANSCRIPTION PRODUCT OF IFRD1
EA200701995A1 (ru) Способы уменьшения кальцификации
MX2013008729A (es) Metodos y composiciones para tratar, reducir, o prevenir el deterioro del sistema visual de los animales.
ZA200805731B (en) Compositions and method for promoting fat loss
MX2013011996A (es) Metodos para regular la expresion de genes de sirtuina.

Legal Events

Date Code Title Description
FG Grant or registration